Shirin Mahmoodi
Overview
Explore the profile of Shirin Mahmoodi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
70
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zahedifard Z, Mahmoodi S, Ghasemian A
Biotechnol Appl Biochem
. 2025 Feb;
PMID: 39985148
As a significant cause of global mortality, the cancer has also economic impacts. In the era of cancer therapy, mitigating side effects and costs and overcoming drug resistance is crucial....
2.
Akhgar S, Noorpisheh Ghadimi S, Farhani I, Ghasemian A, Mahmoodi S, Mardkhoshnood M, et al.
Iran J Allergy Asthma Immunol
. 2024 Nov;
23(4):412-421.
PMID: 39549294
As the most common cause of bacillary dysentery or shigellosis, Shigella sonnei (S nonnei) has spread throughout the world. Invasion of the colorectal epithelial cells by this facultative intracellular bacterium...
3.
Mahmoodi S, Rajeoni A, Zeinolabedini M, Javanmard A, Banabazi M
Vet Med Sci
. 2024 Oct;
10(6):e70004.
PMID: 39422099
Background: The domestic cat (Felis catus) is a newly evolved species in the family Felidae that has developed some great features among mammals. It is critical to conserve these species...
4.
Hashemi P, Osanloo M, Farjadfar A, Nasiri-Ghiri M, Zarenezhad E, Mahmoodi S
Sci Rep
. 2024 Sep;
14(1):22484.
PMID: 39341926
Shigellosis, caused by the Gram-negative bacterium Shigella, is a major global health challenge. Despite extensive research over the past two decades, no commercial vaccine is available to prevent Shigella infection....
5.
Mahmoodi S, Amirzakaria J, Ghasemian A
Biotechnol Appl Biochem
. 2024 Aug;
72(1):58-74.
PMID: 39128888
The emergence or reemergence of monkeypox (Mpox) and Ebola virus (EBOV) agents causing zoonotic diseases remains a huge threat to human health. Our study aimed at designing a multi-epitope vaccine...
6.
BakhshiGanje M, Mahmoodi S, Ahmadi K, Mirabolfathy M
Sci Rep
. 2024 Apr;
14(1):7784.
PMID: 38565553
In Iran, native oak species are under threat from episodes of Charcoal Disease, a decline syndrome driven by abiotic stressors (e.g. drought, elevated temperature) and biotic components, Biscogniauxia mediterranea (De...
7.
Hashemi P, Mahmoodi S, Ghasemian A
Arch Microbiol
. 2023 Jul;
205(8):289.
PMID: 37468763
Various infectious agents affect human health via the oral entrance. The majority of pathogens lack approved vaccines. Oral vaccination is a convenient, safe and cost-effective approach with the potential of...
8.
Satvati S, Ghasemi Y, Najafipour S, Eskandari S, Mahmoodi S, Nezafat N, et al.
Arch Microbiol
. 2023 Jun;
205(7):260.
PMID: 37291420
Superoxide dismutase (SOD) is one of the most important antioxidant enzymes that can reduce oxidative stress in the cell environment. Nowadays, bacterial sources of enzyme are commercially applicable in the...
9.
Mahmoodi S, Amirzakaria J, Ghasemian A
PLoS One
. 2023 May;
18(5):e0285177.
PMID: 37146081
Chikungunya virus (CHIKV) is an emerging viral infectious agent with the potential of causing pandemic. There is neither a protective vaccine nor an approved drug against the virus. The aim...
10.
Abbasi M, Behmard E, Yousefi M, Shekarforoush S, Mahmoodi S
Arch Microbiol
. 2023 Apr;
205(5):199.
PMID: 37069440
Antibiotic-resistant pathogens have become a great universal health concern. Antimicrobial peptides (AMPs) are small amphipathic and cationic polypeptides with high therapeutic potential against various microorganisms containing drug-resistant strains. Two major...